#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Penile squamous cell carcinoma Immune-mediated enterocolitis Thymic carcinoma Extra-osseous Ewing's sarcoma metastatic Pyruvate kinase deficiency anaemia Haemophilia A without inhibitors Aspergillus infection Nephroblastoma Staphylococcal infection Metastases to central nervous system Behcet's syndrome Autoimmune haemolytic anaemia Deafness Osteosarcoma Fibrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Life with Disease Chronic granulomatous disease – Diagnostics Splenic marginal zone lymphoma – Life with Disease Angiosarcoma non-metastatic Hereditary motor and sensory neuropathy – Diagnostics Lymphatic malformation – Trials in Disease CADASIL – Trials in Disease Hereditary neuropathic amyloidosis – Diagnostics VEXAS syndrome – Trials in Disease Arterial tortuosity syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IG-TREGS Pemafibrate ZINC GLUCONATE Permethrin Sodium Fluoride (18F) Morphine Sulfate 204-NETU Mometasone Amivantamab Talquetamab 18F-Fludarabine Anhydrous Cyclophosphamide Img-007 Rbl016.2 Pilocarpine Nitrate Maralixibat Chloride Imgn151 Desoximetasone Indometacin Piperacillin Sodium More therapies…

    Learn about Your Condition

    B-cell lymphoma Gender dysphoria Autism spectrum disorder Renal cancer stage IV Pancreaticoduodenectomy Colon cancer stage II Pharyngeal cancer stage I Pneumothorax Follicular lymphoma stage II Addison's disease Colorectal cancer stage III Myocarditis Carotid artery occlusion Small intestine adenocarcinoma Ocular myasthenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Pirtobrutinib
    Italy

  • Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dyslipidaemia
    • Acute coronary syndrome
    Investigated Drugs:
    • Atorvastatin
    • Inclisiran
    • Rosuvastatin
    France Germany Hungary Poland Spain

  • A study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • K-ras gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Mk-1084
    • Carboplatin
    Finland Greece Italy The Netherlands Poland Spain

  • Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ziftomenib
    • Azacitidine
    • Cytarabine
    Belgium Czechia France Germany Greece Hungary +4

  • Study of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Revumenib
    • Cytarabine
    • Fludarabine Phosphate
    Austria Czechia Denmark Germany Italy The Netherlands +2

  • A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

    Recruiting

    2 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • AZD5148
    Denmark France Germany Greece Hungary Italy +2
Previous Page
1 … 56 57 58 59 60 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!